Absorbable Nasal Implant Devices Market Size

Absorbable Nasal Implant Devices Market Size

Absorbable Nasal Implant Devices Market size surpassed USD 581 million in 2022 and is expected to grow at 7% CAGR from 2023 to 2032. The increasing prevalence of nasal congestions caused by a variety of factors such as allergies, infections, or structural abnormalities are projected to propel the industry growth.

The American College of Allergy, Asthma & Immunology, in 2021, estimates that the nasal congestion is a common health complaint, with an estimated 20 million individuals experience this condition every year in the U.S. Also, the estimates state that up to 30% of adults and 40% of children experience nasal congestion due to allergies. Moreover, the technological advancements in the development of nasal absorbable implants with lowered complications including irritation and other extremities is contributing to the market growth.
 

Absorbable nasal implant devices are medical devices designed to provide temporary support and drug delivery to the nasal cavity. They are typically made of materials that can be absorbed by the body over time, eliminating the need for removal surgery. These devices can be used to treat a variety of nasal conditions such as nasal valve collapse, septal deviation, or inferior turbinate hypertrophy. They are used for drug delivery, releasing medications such as corticosteroids or antibiotics directly to the nasal cavity to treat inflammation or infection.
 

However, the lack of product awareness among the populace regarding nasal implants, particularly absorbable nasal implant devices may impede the market growth. Many people are unaware that these devices exist as a treatment option for nasal conditions such as nasal valve collapse or septal deviation. This lack of awareness is owing to the limited use and knowledge, as these devices are relatively new & are not widely adopted in clinical practice.